Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 205

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 205
---
fusion Equity Award, (2) grants or awards of Enfusion Securities required to be made pursuant to the terms of Enfusion Employee Plans in effect as of the date of the Merger      
 Agreement, (3) the issuance of shares of Enfusion Common Stock and Enfusion Class B Common Stock pursuant to the ESPP in accordance with its terms, subject to the limitations of the Merger Agreement, or (4) the issuance of shares of          
 Enfusion Common Stock and Enfusion Class B Common Stock upon the settlement of exchanges of shares of Enfusion Class B Common Stock and Enfusion Common Units pursuant to Article XII of the Operating Agreement.                                 |

| • |     | amend or otherwise modify any of the terms of any outstanding Enfusion Equity Awards; |

| • |     | adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial liquidation,                                                                                                          
 dissolution, restructuring, merger, consolidation, division, statutory conversion or domestication, share exchange, business combination, reorganization or recapitalization of Enfusion or any of its subsidiaries; |

| • |     | (1) increase or commit to increase the salary, wages, benefits, bonuses or other compensation payable or to                                                                                                                                             
 become payable to Enfusion’s or any of its subsidiaries’ current and former directors, officers, employees, or other non-employee service providers, except (x) as required to be made pursuant to                                                      
 the terms of any Enfusion Employee Plan in effect on the date of the Merger Agreement or (y) pursuant to actions taken to effectuate the treatment of the Enfusion Equity Awards and the ESPP pursuant to the Merger Agreement, including any           
 amendments to the ESPP, (2) become a party to, establish, adopt, amend, commence participation in or terminate any Enfusion Employee Plan or any arrangement that would have been a Enfusion Employee Plan had it been entered into prior to the        
 Merger Agreement (other than with respect to renewal of welfare benefit plans in the ordinary course of business), (3) take any action to accelerate the vesting or lapsing of restrictions or payment, or fund in any other way to secure the payment, 
 of compensation or benefits under any Enfusion Employee Plan, (4) change any                                                                                                                                                                            |

130

| actuarial or other assumptions used to calculate funding obligations with respect to any Enfusion Employee Plan that is required by applicable law to be funded, except for any such changes that                                               
 are required by GAAP (or,